EUVIMEDEUVIMED entdecken
Crossref

Designing a next-generation multi-stage vaccine for malaria prevention

Hemant Arya, Himani Tripathi, Tarun Kumar Bhatt

Microbial Pathogenesis · 2026-07 · 216 · 108502

DOI: 10.1016/j.micpath.2026.108502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026-07. Verfasst von Hemant Arya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Life Sciences, Central University of Rajasthan, Bandarsindri, Kishangarh, Ajmer, Rajasthan, 305817, India. Hauptthemen laut MEDLINE: Malaria Vaccines, Malaria, Plasmodium. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Indian Council of Medical Research, Defence Science and Technology Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria is a potentially fatal parasitic disease that significantly affects human health worldwide. Several drugs are available for malaria treatment, but an alarming increase in Plasmodium drug resistance is of huge concern. To date, only two vaccines, RTS,S/AS01 and R21/Matrix-M, are recommended by the WHO. The present study focuses on designing a multi-epitope subunit vaccine targeting five key Plasmodium proteins using an immunoinformatic approach. Three vaccine constructs comprising adjuvants, cytotoxic T-lymphocyte-binding epitopes, helper T-lymphocyte-binding epitopes, B-cell epitopes, and specific linkers were designed. The assessment of their physicochemical properties revealed that the constructs were antigenic, non-allergenic, and non-toxic. The vaccines' 3D structures were designed, refined, and validated. Molecular docking with the immune receptor TLR-4 revealed the most stable binding to construct 1. The molecular dynamics simulations of the complex with construct 1 revealed strong, stable interactions. The vaccine candidate was evaluated through immune simulations to predict its immunogenic profile. In silico cloning indicated its potential for efficient expression in E. coli. The proposed vaccine construct has shown promising results; however, in vitro and in vivo studies are necessary to validate its efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malaria VaccinesMalariaPlasmodiumHumansMolecular Docking SimulationProtein Subunit VaccinesEpitopes, B-LymphocyteEpitopes, T-LymphocyteMolecular Dynamics SimulationImmunoinformaticsVaccines, SubunitProtozoan ProteinsAntigens, ProtozoanAdjuvants, ImmunologicAnimalsPlasmodium falciparum

Stichwörter der Autor:innen

Circumsporozoite proteinIn silicoMD simulationsMalariaMulti-epitopeVaccine

Substanzen

Malaria VaccinesProtein Subunit VaccinesEpitopes, B-LymphocyteEpitopes, T-LymphocyteVaccines, SubunitProtozoan ProteinsAntigens, ProtozoanAdjuvants, Immunologic

Autor:innen und Institutionen

  • Department of Biotechnology, School of Life Sciences, Central University of Rajasthan, Bandarsindri, Kishangarh, Ajmer, Rajasthan, 305817, India.
  • Department of Biotechnology, School of Life Sciences, Central University of Rajasthan, Bandarsindri, Kishangarh, Ajmer, Rajasthan, 305817, India. Electronic address: tarun@curaj.ac.in.

Förderung

  • Indian Council of Medical Research
  • Defence Science and Technology Group

Zitieren

APA

Arya, H., Tripathi, H., & Bhatt, T. K. (2026). Designing a next-generation multi-stage vaccine for malaria prevention. Microbial Pathogenesis, 216, 108502. https://doi.org/10.1016/j.micpath.2026.108502

Vancouver

Arya H, Tripathi H, Bhatt TK. Designing a next-generation multi-stage vaccine for malaria prevention. Microbial Pathogenesis. 2026;216:108502. doi:10.1016/j.micpath.2026.108502

BibTeX
@article{Arya2026,
  author = {Arya, Hemant and Tripathi, Himani and Bhatt, Tarun Kumar},
  title = {Designing a next-generation multi-stage vaccine for malaria prevention},
  journal = {Microbial Pathogenesis},
  year = {2026},
  volume = {216},
  pages = {108502},
  doi = {10.1016/j.micpath.2026.108502}
}
Kostenlos starten →